Item 7.01 | Regulation FD Disclosure. |
On September 14, 2018, Genworth Holdings, Inc., a direct wholly-owned subsidiary of Genworth Financial, Inc., issued a press release announcing the commencement of a solicitation of consents from the holders of its outstanding 7.700% Senior Notes due 2020, 7.20% Senior Notes due 2021, 7.625% Senior Notes due 2021, 4.900% Senior Notes due 2023, 4.800% Senior Notes due 2024 and 6.500% Senior Notes due 2034 (collectively, the “Notes”) proposing amendments to the indenture governing the Notes in accordance with the terms and subject to the conditions set forth in that certain Consent Solicitation Statement dated September 14, 2018, which are being sent to the holders of the Notes. A copy of the Consent Solicitation Statement, which is attached hereto as Exhibit 99.1, is incorporated by reference into this Item 7.01. A copy of the press release announcing the Consent Solicitation is attached hereto as Exhibit 99.2.
The information furnished pursuant to Item 7.01 (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information contained in Item 7.01 (including Exhibits 99.1 and 99.2) shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
On September 14, 2018, Genworth Financial, Inc. issued, jointly with China Oceanwide Holdings Group Co., Ltd. (“Oceanwide”), a press release announcing that they are submitting supplemental information to the regulators who are reviewing their proposed transaction. The supplemental filings are being submitted to, among other things, outline a potential alternative funding structure for the transaction that Oceanwide may implement in the event that international political and economic developments cause potential delays in implementing the original funding structure.
The closing of the transaction remains subject to other conditions under the Merger Agreement, including the receipt of required regulatory approvals in the U.S., China and other international jurisdictions.
A copy of the press release announcing the submission of supplemental information to regulators is attached hereto as Exhibit 99.3.
Item 9.01 | Financial Statements and Exhibits. |
The following are furnished as exhibits to this Current Report on Form8-K: